A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease.

Autor: Bhatt VR; Division of Hematology-Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE., Shostrom VK; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE., Choe HK; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH., Hamilton BK; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Gundabolu K; Division of Hematology-Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE., Maness LJ; Division of Hematology-Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE., Kumar V; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE., Mahato RI; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE., Smith LM; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center and Department of Medicine, University of Washington, Seattle, WA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 20; Vol. 42 (33), pp. 3977-3985. Date of Electronic Publication: 2024 Aug 16.

The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.

Autor: Sudalagunta PR; Moffitt Cancer Center, Tampa, Florida, United States., Canevarolo RR; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States., Meads MB; Moffitt Cancer Center, Tampa, FL, United States., Silva M; Moffitt Cancer Center, Tampa, United States., Zhao X; Moffitt Cancer Center, Tampa, FL, United States., Cubitt CL; Moffitt Cancer Center, Tampa, FL, United States., Sansil SS; Moffitt Cancer Center, Tampa, FL, United States., DeAvila G; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States., Alugubelli RR; Moffitt Cancer Center, Tampa, FL, United States., Bishop RT; Moffitt Cancer Center, Tampa, FL, United States., Tungesvik A; University of Iowa, United States., Zhang Q; AsterInsights, Tampa, Florida, United States., Hampton O; Aster Insights, United States., Teer JK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Welsh EA; Moffitt Cancer Center, Tampa, United States., Yoder SJ; Moffitt Cancer Center, Tampa, FL, United States., Shah BD; H. Lee Moffitt Cancer Center & Research Institute, Tampa, United States., Hazlehurst L; West Virginia University, Morgantown, WV, United States., Gatenby RA; Moffitt Cancer Center, Tampa, FL, United States., Van Domelen DR; Karyopharm Therapeutics (United States), United States., Chai Y; Karyopharm Therapeutics (United States), United States., Wang F; The University of Texas MD Anderson Cancer Center, Houston, United States., DeCastro A; Karyopharm Therapeutics (United States), United States., Bloomer AM; H. Lee Moffitt Cancer Center & Research Institute, United States., Siegel EM; Moffitt Cancer Center, Tampa, FL, United States., Lynch CC; Moffitt Cancer Center, Tampa, FL, United States., Sullivan DM; Moffitt Cancer Center, Tampa, FL, United States., Alsina M; Moffitt Cancer Center, Tampa, FL, United States., Nishihori T; Moffitt Cancer Center, Tampa, FL, United States., Brayer J; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States., Cleveland JL; Moffitt Cancer Center, Tampa, FL, United States., Dalton W; Moffitt Cancer Center, Tampa, FL, United States., Walker CJ; Karyopharm Therapeutics, Inc., United States., Landesman Y; Karyopharm Therapeutics Inc, Newton, MA, United States., Baz R; Moffitt Cancer Center, Tampa, United States., Silva AS; Moffitt Cancer Center, Tampa, FL, United States., Shain KH; Moffitt Cancer Center, Tampa, FL, United States.

Publikováno v: Cancer research [Cancer Res] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study.

Autor: Kahn J; Department of Pediatrics, Columbia University Medical Center, New York, NY, USA., Brazauskas R; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Bo-Subait S; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Buchbinder D; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, CA, USA., Hamilton BK; Blood & Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Schoemans H; Department of Hematology, UZ Leuven, Leuven, Belgium; Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium., Abraham AA; Division of Blood and Marrow Transplantation, Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA., Agrawal V; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA., Auletta JJ; Hematology/Oncology/BMT Clinic and Infectious Diseases Clinic, Nationwide Children's Hospital, Columbus, OH, USA., Badawy SM; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami, Miami, FL, USA; Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami, FL, USA., Bhatt NS; Division of Hematology/Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Broglie L; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA., Diaz Perez MA; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain., Farhadfar N; Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA., Freytes CO; University of Texas Health Science Center San Antonio, San Antonio, TX, USA., Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK., Ganguly S; Houston Methodist Neal Cancer Center, Houston, TX, USA., Hayashi RJ; Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Hematti P; BMT and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Hildebrandt GC; University of Missouri, Ellis Fischel Cancer Center, Columbia, MO, USA., Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Kamble RT; Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA., Koo J; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA., Mayo SJ; Lawrence S Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Mehta PA; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Myers KC; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Nishihori T; Blood and Marrow Transplant and Cellular Immunotherapy Program, Moffitt Cancer Center, Tampa, FL, USA; Department of Oncologic Sciences, Morsani College of Medicine, University South of Florida, Tampa, FL, USA., Prestidge T; Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand., Rotz SJ; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Schears RM; Department of Emergency Medicine, University of Central Florida, Orlando, FL, USA., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Stenger E; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA., Ustun C; Division of Hematology, Oncology and Cell Therapy, Rush University, Chicago, IL, USA., Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA., Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Satwani P; Department of Pediatrics, Columbia University Medical Center, New York, NY, USA., Phelan R; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA; Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: rphelan@mcw.edu.

Publikováno v: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2024 Oct; Vol. 8 (10), pp. 740-750. Date of Electronic Publication: 2024 Aug 30.

Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy.

Autor: Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida. Electronic address: aasha.hoogland@moffitt.org., Barata A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Irizarry-Arroyo N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Jain MD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Welniak T; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Chavez JC; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Khimani F; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Lazaryan A; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Liu HD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Pinilla-Ibarz J; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Shah BD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Parker NH; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Vinci CE; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Pidala JA; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Logue J; Moffitt Malignant Hematology & Cellular Therapy, Memorial Healthcare System, Pembroke Pines, Florida., Locke FL; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.

Autor: Jain T; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Estrada-Merly N; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Salas MQ; Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology, Hospital Clínic de Barcelona, Barcelona, Spain., Kim S; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., DeVos J; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Chen M; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Fang X; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Kumar R; Princess Margaret Cancer Centre, Toronto, Canada., Andrade-Campos M; Hospital del Mar Research Institute, Barcelona, Spain., Elmariah H; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Center and Research Institute, Tampa, FL., Agrawal V; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Aljurf M; Oncology Center, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia., Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Badar T; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Badawy SM; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL.; Division of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Ballen K; Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL., Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE., Bredeson C; The Ottawa Hospital Transplantation and Cellular Therapy Program and Ottawa Hospital Research Institute, Ottawa, ON, Canada., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA., Dholaria B; Vanderbilt University Medical Center, Nashville, TN., Farhadfar N; Sarah Cannon Transplant & Cellular Program at Methodist Hospital, San Antonio, TX., Farhan S; Henry Ford Health System Stem Cell Transplant & Cellular Therapy Program, Detroit, MI., Gandhi AP; Division of Hematology/Medical Oncology, Oregon Health and Science University, Portland, OR., Ganguly S; Houston Methodist Hospital and Neal Cancer Center, Houston, TX., Gergis U; Division of Hematological Malignancies, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC., Hamad N; Department of Hematology, St. Vincent's Hospital Sydney, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.; School of Medicine, University of Notre Dame, Sydney, Australia., Hamilton BK; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Inamoto Y; Department of BMT & Cellular Therapy, Fujita Health University School of Medicine, Toyoake, Japan., Iqbal M; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Jamy O; University of Alabama at Birmingham, Birmingham, AL., Juckett M; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN., Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Krem MM; Kansas City VA Medical Center, Kansas City, MO., Lad DP; Leukemia/Bone Marrow Transplant Program of British Columbia, Division of Hematology, Department of Medicine, The University of British Columbia, Vancouver, Canada., Liesveld J; Department of Medicine, University of Rochester Medical Center, Rochester, NY., Al Malki MM; City of Hope National Medical Center, Duarte, CA., Malone AK; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Ortí G; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Patel SS; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT., Pawarode A; Adult Blood and Marrow Transplantation and Cellular Therapy, Rogel Cancer Center, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI., Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., van der Poel M; Division of Hematology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Ringden O; Translational Cell Therapy Group, Clinical Science, Intervention, and Technology Karolinska Institutet, Stockholm, Sweden., Rizzieri DA; Novant Health Cancer Institute, Winston Salem, NC., Rovó A; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Savoie ML; University of Calgary, Calgary, AB, Canada., Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan., Solh M; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA., Ustun C; Division of Hematology, Oncology, and Cell Therapy, RUSH University, Chicago, IL., Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands., Wingard JR; Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL., Wirk B; Virginia Commonwealth University, Massey Comprehensive Cancer Center, Richmond, VA., Bejanyan N; Department of Bone Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Center and Research Institute, Tampa, FL., Jones RJ; Division of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Department of Oncologic Sciences, Morsani College of Medicine, University South of Florida, Tampa, FL., Oran B; Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX., Nakamura R; City of Hope National Medical Center, Duarte, CA., Scott B; Fred Hutchinson Cancer Research Center, Seattle, WA., Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI., Gupta V; Princess Margaret Cancer Centre, Toronto, Canada.

Publikováno v: Blood advances [Blood Adv] 2024 Aug 27; Vol. 8 (16), pp. 4281-4293.